Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma

Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma

<b>Background</b>: Leiomyosarcomas (LMS) are aggressive malignancies with a propensity for early relapse. Current surveillance modalities include physical exam and imaging; however, radiological response to therapy may only manifest after 4–6 cycles of treatment. Herein, we evaluated the...

Full description

Bibliographic Details
Main Authors: Maggie Zhou, Nam Bui, Richa Rathore, Sumedha Sudhaman, Giby V. George, Allyson K. Malashevich, Meenakshi Malhotra, Minetta C. Liu, Alexey Aleshin, Kristen N. Ganjoo
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
leiomyosarcoma
circulating tumor DNA
soft tissue sarcomas
Online Access:https://www.mdpi.com/2072-6694/15/1/157

Internet

https://www.mdpi.com/2072-6694/15/1/157

Similar Items